July 22, 2021 07:23 AM EDTUpdated July 27, 04:52 PM

Covid-19 roundup: Regeneron asks FDA: Which government agencies are tracking variants of concern?; Pfizer, AstraZeneca vaccines mostly hold strong against Delta variant

Nicole DeFeudis

Editor

Zachary Brennan

Senior Editor

As the race to keep Covid-19 variants at bay continues, Regeneron is calling on the FDA to provide additional clarity on which government agencies are …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Regeneron asks FDA: Which government agencies are tracking variants of concern?; Pfizer, AstraZeneca vaccines mostly hold strong against Delta variant

Nicole DeFeudis

Editor

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Patient dies in Neurogene's Rett syndrome study

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Are programs with compounded GLP-1s safe for your population?

Covid-19 roundup: Re­gen­eron asks FDA: Which gov­ern­ment agen­cies are track­ing vari­ants of con­cern?; Pfiz­er, As­traZeneca vac­cines most­ly hold strong against Delta vari­ant

Editor

Senior Editor

Sign up to read this article for free.

Covid-19 roundup: Regeneron asks FDA: Which government agencies are tracking variants of concern?; Pfizer, AstraZeneca vaccines mostly hold strong against Delta variant